Core Viewpoint - A securities class action lawsuit has been filed against Civitas Resources, Inc. for alleged issues during the Class Period from February 27, 2024, to February 24, 2025 [1][2]. Financial Performance - Civitas reported Q4 and full-year 2024 revenue of $1.29 billion, which missed consensus estimates by $3.44 million [3]. - The company posted non-GAAP earnings per share of $1.78 for Q4 2024, falling short of consensus estimates by $0.21 per share [3]. - Net income for the quarter was $151.1 million, or $1.57 per share, a significant decrease from $302.9 million, or $3.23 per share, in the same quarter the previous year [3]. Operational Outlook - Civitas's 2025 outlook indicated lower production volumes primarily due to natural declines in the DJ Basin following peak production in Q4 2024 [4]. - The company announced a 10% reduction in its workforce across all levels [4]. - The termination of Chief Operating Officer Hodge Walker and Chief Transformation Officer Jerome Kelly was also disclosed [4]. Market Reaction - Following the announcement of the financial results and operational changes, Civitas's stock price dropped by $8.95 per share, or 18%, closing at $40.35 per share on February 25, 2025 [5].

21 June 2025 | 4:02AM HKT Asia Credit Trader China Property Debt Restructuring Still A Slow Burn Despite rising tensions in the Middle East and the spike in oil prices, Asia credit largely marched to its own tune, with spreads little changed over the week. We believe that, unless geopolitical events and/or impact from trade tariffs begin to have notable negative impact on the Global economy and recession risks re-emerge, Asia credit will continue to climb the "wall of worry", with the need to maintain carry ...

Core Insights - Outlook Therapeutics, Inc. is participating in a Virtual Investor Lunch Break Event on June 25, 2025, at 12:00 PM ET [1] - Key executives will discuss the company's commercial strategy, upcoming milestones, and current activities during the event [2] - A live video webcast will be available on the company's website, with a replay accessible for 90 days [3] Company Overview - Outlook Therapeutics focuses on the development and commercialization of ONS-5010/LYTENAVA™ (bevacizumab-vikg) to enhance the standard of care for retinal diseases [4] - LYTENAVA™ is the first ophthalmic formulation of bevacizumab to receive marketing authorization in Europe for the treatment of wet AMD [4] - The commercial launch of LYTENAVA™ has commenced in Germany and the UK [4] Regulatory Status - In the United States, ONS-5010/LYTENAVA™ is currently investigational, with a Biologics License Application (BLA) resubmitted to the FDA [5] - If approved, it would be the first ophthalmic formulation of bevacizumab for retinal indications, including wet AMD [5]

HAUPPAUGE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (the “Company” or “Dime”) (NASDAQ: DCOM), the parent company of Dime Community Bank (the “Bank”), announced that Kroll Bond Rating Agency (“KBRA”), in a report dated June 17, 2025, revised its ratings outlook from “Stable” to “Positive.” Kroll’s deposit and senior unsecured debt rating for Dime Community Bank is BBB+. According to the KBRA report, the revision of the Outlook to “Positive” primarily reflects the strong executi ...

Core Viewpoint - First Horizon Corporation's credit ratings outlook has been upgraded to positive by Moody's, reflecting improvements in its regional banking franchise and deposit quality [1][9]. Group 1: Ratings and Outlook - Moody's upgraded First Horizon's long-term issuer rating and senior unsecured notes, affirming its Baa3 long-term issuer rating [1]. - The positive outlook is attributed to First Horizon's strengthening regional banking franchise in the Southeast and effective risk management [2][6]. - Moody's expects ongoing improvements in asset quality and funding despite uncertain economic conditions [2]. Group 2: Financial Performance - First Horizon has demonstrated consistent performance with decent asset quality, strong capitalization, and adequate liquidity [3]. - The bank's tangible common equity (TCE) ratio is 10.6% and the CET1 ratio is 10.9% as of March 2025, both within or slightly above target ranges [5]. - Profitability is recovering, supported by specialty lending and effective deposit pricing management, although fee income remains volatile [5][9]. Group 3: Risk Management and Future Prospects - Moody's noted that an upgrade is likely if First Horizon continues prudent risk management and improves deposit quality [7]. - The bank's deposit franchise has shown resilience, particularly after the collapse of its planned merger with Toronto-Dominion Bank [4]. - Ongoing improvements in capital, asset quality, and funding diversification support the positive outlook [6]. Group 4: Market Performance - Over the past year, First Horizon's shares have increased by 36.5%, outperforming the industry's growth of 24.4% [8].

Core Insights - Comerica Incorporated (CMA) has revised its second-quarter 2025 outlook for loans and deposits, indicating a decline in average deposits and an increase in average loans compared to previous guidance [1][3][7] Group 1: Deposit Trends - Average deposits for the quarter to date through May 31, 2025, have decreased by $0.6 billion compared to the first quarter, with significant declines noted in middle market, retail, and corporate banking [1][2][7] - The bank's previous guidance anticipated average deposits to remain flat from the first quarter's $61.9 billion, but current trends suggest downward pressure on this outlook [2][7] Group 2: Loan Performance - Average loans for the quarter to date have increased by $200 million from the previous quarter, driven by growth in corporate and private banking, although this was partially offset by declines in equity fund services and national dealer services [3][7] - Comerica now expects average loan balances to outperform earlier guidance, which had projected a slight decline from the first quarter's $50.2 billion [3][7] Group 3: Income and Expenses - Net interest income (NII) for the second quarter is projected to be relatively flat at $575 million, with a 5-7% increase anticipated for 2025 compared to 2024 [4] - Non-interest income is expected to show stronger growth from the first quarter's $254 million, with a projected 2% year-over-year increase for 2025 [4] - Non-interest expenses are anticipated to be slightly higher than the previous quarter's $584 million, with a 2-3% rise expected for 2025 compared to 2024 [5] Group 4: Market Performance - CMA shares have declined by 7% year-to-date, contrasting with a 2.7% decline in the industry [6]

LOS GATOS, Calif., June 13, 2025 /PRNewswire/ -- Netflix, Inc. (NASDAQ: NFLX) today announced it will post its second quarter 2025 financial results and business outlook on its investor relations website at http://ir.netflix.net on Thursday, July 17, 2025, at approximately 1:01 p.m. Pacific Time.A live video interview with co-CEOs Ted Sarandos and Greg Peters, Chief Financial Officer Spence Neumann and VP, Finance/IR & Corporate Development Spencer Wang will begin at 1:45 p.m. Pacific Time. Management will ...

Simulations Plus Inc SLP stock tanked after the company lowered its fiscal 2025 sales outlook.The company expects third-quarter sales of $19 million-$20 million, much below the consensus of $22.78 million.On Wednesday, the company cut its 2025 sales forecast to $76 million—$80 million versus a consensus of $90.26 million, down from prior guidance of $90 million—$93 million.Also Read: What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?"Market uncertainties surrounding future fundi ...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday.The Dow traded down 0.03% to 42,852.84 while the NASDAQ gained 0.24% to 19,663.38. The S&P 500 also rose, gaining, 0.26% to 6,038.05.Check This Out: Jim Cramer Is All Aboard Union Pacific, But Shows No Love For Orphan DrugsLeading and Lagging SectorsInformation technology shares jumped by 0.9% on Thursday.In trading on Thursday, industrials stocks fell by 0.5%.Top HeadlineShares of Oracle Corp. OR ...

Pet e-tailer Chewy Inc (NYSE:CHWY) reported a first-quarter earnings miss before the open, overshadowing its revenue beat. The company issued a lackluster full-year outlook, too, despite recent customer growth. At last check, CHWY was down 11.3% to trade at $40.63. Shares are now on track for their third-straight loss, as well as their worst day since August 2023. The equity is pulling back from its June 6, two-year high of $48.62, but support from the 40-day moving average could contain today's losses. For ...